Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
On 29 March 2022, Telix Pharmaceuticals Limited (ASX: TLX) made two announcements. Post their release of announcements on ASX, the Company's shares moved up by 7.469% and were trading at AU$4.460 (AEDT 1:10 PM). In this article, we will look at these two announcements.
On 29 March 2022, Telix Pharmaceuticals Limited (ASX: TLX) made two announcements. Post their release of announcements on ASX, the Company's shares moved up by 7.469% and were trading at AU$4.460 (AEDT 1:10 PM). In this article, we will look at these two announcements.
Apr 28, 2025
Apr 28, 2025
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 14, 2025
Apr 11, 2025
Apr 11, 2025
Apr 10, 2025
Apr 10, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is based in Australia. The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
